Product Information
VRAYLAR 3 MG CAPSULE is a brand product labeled by Allergan, Inc., priced at $50.8820 per EA under NDC 61874013020. Its NADAC has been published 472 times since Jun 14, 2017.
Strength
3 mg/1
Manufacturer
Allergan, Inc.NDC
61874013020
Classification
Brand
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARIPRAZINEApproval Type
New Drug (NDA)
FDA Application
NDA204370On Market Since
9/17/2015
Pharmacological Classes
Price Statistics
The NADAC for VRAYLAR 3 MG CAPSULE has been published 472 times since Jun 14, 2017, and over the history we have for it it has risen 45.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $50.8820 per EA |
|---|---|
| All-time high | $50.9560 (May 13, 2026) |
| All-time low | $34.9242 (Jun 14, 2017) |
| 52-week high | $50.9560 |
| 52-week low | $48.5093 |
| Median price | $40.5225 |
| Average price | $42.1226 |
| Largest weekly change | +9.5% (Jan 10, 2018) |
| Weeks tracked | 472 |
| Tracking since | Jun 14, 2017 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VRAYLAR 3 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VRAYLAR 3 MG CAPSULE, manufactured by Allergan, Inc., is $50.8820 per EA (NDC 61874013020), effective Jun 24, 2026.
How has the price of VRAYLAR 3 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VRAYLAR 3 MG CAPSULE has risen 45.7%. It has been tracked across 472 weekly CMS publications since Jun 14, 2017.
What are the highest and lowest recorded NADAC prices for VRAYLAR 3 MG CAPSULE?
Since Jun 14, 2017, the NADAC for VRAYLAR 3 MG CAPSULE has ranged from a low of $34.9242 (Jun 14, 2017) to a high of $50.9560 (May 13, 2026), with a median of $40.5225 per EA.
Are there cheaper alternatives to VRAYLAR 3 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as VRAYLAR 3 MG CAPSULE, but none are currently priced below it.
Who manufactures VRAYLAR 3 MG CAPSULE?
VRAYLAR 3 MG CAPSULE (NDC 61874013020) is labeled by Allergan, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification